Malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers in animal models. from Medindia Health News https://ift.tt/tvJoR7q
No comments
Thanks for comment via will connect you within 24 hours.